Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot3
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot3
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
{
"resourceType" : "Composition",
"id" : "267224",
"meta" : {
"versionId" : "12",
"lastUpdated" : "2026-07-23T15:52:50.865Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-report"
]
},
"language" : "en",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Composition 267224</b></p><a name=\"267224\"> </a><a name=\"hc267224\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 12; Last updated: 2026-07-23 15:52:50+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-evidence-report.html\">EvidenceReport</a></p></div><p><b>Artifact Description</b>: </p><div><p>An evidence report summarizing the Results Section of a ClinicalTrials.gov record entry</p>\n</div><p><b>ArtifactPublicationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/cited-artifact-status-type active}\">Active</span></p><p><b>url</b>: <a href=\"https://fevir.net/resources/Composition/267224\">https://fevir.net/resources/Composition/267224</a></p><p><b>identifier</b>: FEvIR Object Identifier/267224, <a href=\"http://terminology.hl7.org/7.3.0/NamingSystem-ClinicalTrials-Gov.html\" title=\"The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed [ClinicalTrials.gov](http://clinicaltrials.gov) to provide patients, family members, and members of the public current information about clinical research studies. [ClinicalTrials.gov](http://clinicaltrials.gov) contains summary information about clinical studies being conducted throughout the United States and in many countries throughout the world. These data are provided to the National Library of Medicine by organizations and institutions that sponsor and implement the studies.\r\n\r\n[ClinicalTrials.gov](http://clinicaltrials.gov) is updated daily. You should check [ClinicalTrials.gov](http://clinicaltrials.gov) frequently for updated information.\r\n\r\nMore information about ClinicalTrials.gov can be found [here](https://clinicaltrials.gov/about-site/about-ctg).\">ClinicalTrials.gov</a>/NCT03421379\u00a0(use:\u00a0official,\u00a0), FEvIR Linking Identifier/NCT03421379 Results Report</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:\">EvidenceReport</span></p><p><b>category</b>: <span title=\"Codes:\">ClinicalTrials.gov Study Results</span></p><p><b>date</b>: 2026-07-23 15:52:50+0000</p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"http://terminology.hl7.org/7.3.0/CodeSystem-usage-context-type.html#usage-context-type-program\">UsageContextType: program</a> (Program)</td><td><span title=\"Codes:\">ClinicalTrials.gov</span></td></tr></table><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter</p><p><b>name</b>: NCT03421379_Results</p><p><b>title</b>: Results Section for NCT03421379</p><p><b>custodian</b>: <a href=\"Organization-118079.html\">Computable Publishing LLC</a></p><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Derived From</p><p><b>target</b>: <a href=\"https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&max_rnk=1&fmt=JSON\">https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&max_rnk=1&fmt=JSON</a></p></blockquote><blockquote><p><b>relatesTo</b></p><p><b>type</b>: Cite As</p><p><b>target</b>: </p><div><p>Results Section for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267224. Revised 2026-07-23. Available at: https://fevir.net/resources/Composition/267224. Computable resource at: https://fevir.net/resources/Composition/267224#json.</p>\n</div></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: PractitionerRole #PointOfContact</b></p><a name=\"267224/PointOfContact\"> </a><a name=\"hc267224/PointOfContact\"> </a><p><b>practitioner</b>: Chief Medical Officer</p><p><b>organization</b>: Eli Lilly and Company</p><h3>Contacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Telecom</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"mailto:ClinicalTrials.gov@lilly.com\">ClinicalTrials.gov@lilly.com</a></td></tr><tr><td style=\"display: none\">*</td><td>ph: 800-545-5979</td></tr></table></blockquote></div>"
},
"contained" : [
{
"resourceType" : "PractitionerRole",
"id" : "PointOfContact",
"practitioner" : {
"display" : "Chief Medical Officer"
},
"organization" : {
"display" : "Eli Lilly and Company"
},
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "ClinicalTrials.gov@lilly.com"
}
]
},
{
"telecom" : [
{
"system" : "phone",
"value" : "800-545-5979"
}
]
}
]
}
],
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-description",
"valueMarkdown" : "An evidence report summarizing the Results Section of a ClinicalTrials.gov record entry"
},
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code" : "active",
"display" : "Active"
}
]
}
}
],
"url" : "https://fevir.net/resources/Composition/267224",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net/FOI",
"value" : "267224",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
{
"use" : "official",
"system" : "https://clinicaltrials.gov/nctid",
"value" : "NCT03421379"
},
{
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03421379 Results Report",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"status" : "final",
"type" : {
"text" : "EvidenceReport"
},
"category" : [
{
"text" : "ClinicalTrials.gov Study Results"
}
],
"subject" : [
{
🔗 "reference" : "ResearchStudy/267223",
"type" : "ResearchStudy",
"identifier" : {
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03421379 FHIR Transform",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
"display" : "A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus"
}
],
"date" : "2026-07-23T15:52:50.865Z",
"useContext" : [
{
"code" : {
"system" : "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code" : "program",
"display" : "Program"
},
"valueCodeableConcept" : {
"text" : "ClinicalTrials.gov"
}
}
],
"author" : [
{
"display" : "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
],
"name" : "NCT03421379_Results",
"title" : "Results Section for NCT03421379",
"custodian" : {
🔗 "reference" : "Organization/118079",
"type" : "Organization",
"display" : "Computable Publishing LLC"
},
"relatesTo" : [
{
"type" : "derived-from",
"targetUri" : "https://clinicaltrials.gov/api/query/full_studies?expr=NCT03421379&max_rnk=1&fmt=JSON"
},
{
"type" : "cite-as",
"targetMarkdown" : "Results Section for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267224. Revised 2026-07-23. Available at: https://fevir.net/resources/Composition/267224. Computable resource at: https://fevir.net/resources/Composition/267224#json."
}
],
"section" : [
{
"title" : "Participant Flow Module",
"code" : {
"text" : "ParticipantFlowModule"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Composition/399871",
"type" : "Composition",
"identifier" : {
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03421379-participant-flow-report",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
"display" : "Participant Flow Report for NCT03421379"
}
]
},
{
"title" : "Baseline Characteristics Module",
"code" : {
"text" : "BaselineCharacteristicsModule"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Composition/399872",
"type" : "Composition",
"identifier" : {
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03421379-baseline-measure-report",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
"display" : "Baseline Characteristics Report for NCT03421379"
}
]
},
{
"title" : "Outcome Measures Module",
"code" : {
"text" : "OutcomeMeasuresModule"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Composition/399873",
"type" : "Composition",
"identifier" : {
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03421379-outcome-measure-report",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
"display" : "Outcome Measures Report for NCT03421379"
}
]
},
{
"title" : "Adverse Events Module",
"code" : {
"text" : "AdverseEventsModule"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>"
},
"entry" : [
{
🔗 "reference" : "Composition/399874",
"type" : "Composition",
"identifier" : {
"type" : {
"text" : "FEvIR Linking Identifier"
},
"system" : "https://fevir.net/FLI",
"value" : "NCT03421379-adverse-events-report",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
"display" : "Adverse Events Report for NCT03421379"
}
]
},
{
"title" : "More Info Module",
"code" : {
"text" : "MoreInfoModule"
},
"text" : {
"status" : "empty",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No narrative text.]</p></div>"
},
"section" : [
{
"title" : "Certain Agreement",
"code" : {
"text" : "CertainAgreement"
},
"entry" : [
{
"display" : "AgreementPISponsorEmployee False"
},
{
"display" : "AgreementRestrictionType GT60"
},
{
"display" : "AgreementRestrictiveAgreement True"
}
]
},
{
"title" : "Point Of Contact",
"code" : {
"text" : "PointOfContact"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Chief Medical Officer, Eli Lilly and Company</div>"
},
"entry" : [
{
"reference" : "#PointOfContact",
"type" : "PractitionerRole",
"display" : "Chief Medical Officer, Eli Lilly and Company"
}
]
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-ballot3.
Generated
2026-07-27
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change